David E Ost1, Jiangong Niu2, Linda S Elting2, Thomas A Buchholz3, Sharon H Giordano2. 1. Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: dost@mdanderson.org. 2. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX. 3. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Abstract
BACKGROUND: Guidelines recommend mediastinal lymph node sampling as the first invasive test in patients with suspected lung cancer with mediastinal lymphadenopathy without distant metastases, but there are no comparative effectiveness studies on how test sequencing affects outcomes. The objective was to compare practice patterns and outcomes of diagnostic strategies in patients with lung cancer. METHODS: The study included a retrospective cohort of 15,316 patients with lung cancer with regional spread without distant metastases in the Surveillance, Epidemiology, and End Results or Texas Cancer Registry Medicare-linked databases. If the first invasive test involved mediastinal sampling, patients were classified as receiving guideline-consistent care; otherwise, they were classified as receiving guideline-inconsistent care. We used propensity matching to compare the number of tests performed and multivariate logistic regression to compare the frequency of complications. RESULTS: Twenty-one percent of patients had guideline-consistent diagnostic evaluations. Among patients with non-small cell lung cancer, 44% never had mediastinal sampling. Patients who had guideline-consistent care required fewer tests than those with guideline-inconsistent care (P < .0001), including thoracotomies (49% vs 80%, P < .001) and CT image-guided biopsies (9% vs 63%, P < .001), although they had more transbronchial needle aspirations (37% vs 4%, P < .001). The consequence was that patients with guideline-consistent care had fewer pneumothoraxes (4.8% vs 25.6%, P < .0001), chest tubes (0.7% vs 4.9%, P < .001), hemorrhages (5.4% vs 10.6%, P < .001), and respiratory failure events (5.3% vs 10.5%, P < .001). CONCLUSIONS: Guideline-consistent care with mediastinal sampling first resulted in fewer tests and complications. We found three quality gaps: failure to sample the mediastinum first, failure to sample the mediastinum at all in patients with non-small cell lung cancer, and overuse of thoracotomy.
BACKGROUND: Guidelines recommend mediastinal lymph node sampling as the first invasive test in patients with suspected lung cancer with mediastinal lymphadenopathy without distant metastases, but there are no comparative effectiveness studies on how test sequencing affects outcomes. The objective was to compare practice patterns and outcomes of diagnostic strategies in patients with lung cancer. METHODS: The study included a retrospective cohort of 15,316 patients with lung cancer with regional spread without distant metastases in the Surveillance, Epidemiology, and End Results or Texas Cancer Registry Medicare-linked databases. If the first invasive test involved mediastinal sampling, patients were classified as receiving guideline-consistent care; otherwise, they were classified as receiving guideline-inconsistent care. We used propensity matching to compare the number of tests performed and multivariate logistic regression to compare the frequency of complications. RESULTS: Twenty-one percent of patients had guideline-consistent diagnostic evaluations. Among patients with non-small cell lung cancer, 44% never had mediastinal sampling. Patients who had guideline-consistent care required fewer tests than those with guideline-inconsistent care (P &lt; .0001), including thoracotomies (49% vs 80%, P &lt; .001) and CT image-guided biopsies (9% vs 63%, P &lt; .001), although they had more transbronchial needle aspirations (37% vs 4%, P &lt; .001). The consequence was that patients with guideline-consistent care had fewer pneumothoraxes (4.8% vs 25.6%, P &lt; .0001), chest tubes (0.7% vs 4.9%, P &lt; .001), hemorrhages (5.4% vs 10.6%, P &lt; .001), and respiratory failure events (5.3% vs 10.5%, P &lt; .001). CONCLUSIONS: Guideline-consistent care with mediastinal sampling first resulted in fewer tests and complications. We found three quality gaps: failure to sample the mediastinum first, failure to sample the mediastinum at all in patients with non-small cell lung cancer, and overuse of thoracotomy.
Authors: Kazuhiro Yasufuku; Andrew Pierre; Gail Darling; Marc de Perrot; Thomas Waddell; Michael Johnston; Gilda da Cunha Santos; William Geddie; Scott Boerner; Lisa W Le; Shaf Keshavjee Journal: J Thorac Cardiovasc Surg Date: 2011-10-02 Impact factor: 5.209
Authors: Raymond U Osarogiagbon; Jeffrey W Allen; Aamer Farooq; Allen Berry; Thomas O'Brien Journal: Ann Thorac Surg Date: 2011-05 Impact factor: 4.330
Authors: Farhood Farjah; David R Flum; Scott D Ramsey; Patrick J Heagerty; Rebecca Gaston Symons; Douglas E Wood Journal: J Thorac Oncol Date: 2009-03 Impact factor: 15.609
Authors: Oisin J O'Connell; Francisco A Almeida; Michael J Simoff; Lonny Yarmus; Ray Lazarus; Benjamin Young; Yu Chen; Roy Semaan; Timothy M Saettele; Joseph Cicenia; Harmeet Bedi; Corrine Kliment; Liang Li; Sonali Sethi; Javier Diaz-Mendoza; David Feller-Kopman; Juhee Song; Thomas Gildea; Hans Lee; Horiana B Grosu; Michael Machuzak; Macarena Rodriguez-Vial; George A Eapen; Carlos A Jimenez; Roberto F Casal; David E Ost Journal: Am J Respir Crit Care Med Date: 2017-06-15 Impact factor: 21.405
Authors: Lucas W Thornblade; Douglas E Wood; Michael S Mulligan; Alexander S Farivar; Michal Hubka; Kimberly E Costas; Bahirathan Krishnadasan; Farhood Farjah Journal: J Thorac Cardiovasc Surg Date: 2018-02-09 Impact factor: 5.209
Authors: Satish K Kedia; Kenneth D Ward; Siri A Digney; Bianca M Jackson; April L Nellum; Laura McHugh; Kristina S Roark; Orion T Osborne; Fayre J Crossley; Nicholas Faris; Raymond U Osarogiagbon Journal: Transl Lung Cancer Res Date: 2015-08
Authors: Brandon T Mullins; Dominic T Moore; M Patricia Rivera; Lawrence B Marks; Jason Akulian; Kevin A Pearlstein; Kyle Wang; Allen C Burks; Ashley A Weiner Journal: J Thorac Dis Date: 2021-02 Impact factor: 2.895